Oct. 31, 2011
Bacterin International Holdings, Inc.
(NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at the Lazard Capital Markets 8th Annual Healthcare Conference. The conference will be held at The Pierre Hotel in
New York City
November 15-16, 2011
Bacterin's chairman and CEO,
, and CFO,
, are scheduled to present on
Wednesday, November 16, 2011
11:30 a.m. Eastern time
, with one-on-one meetings held throughout the day. Management will discuss the company's business plan and objectives for the remainder of 2011.
The presentation will be available via webcast at
. A replay link will also be available for 90 days following the live presentation on the company's website at
Bacterin reported record revenue for the second quarter 2011 of
, up 25% sequentially and 135% year-over-year. The company also reported its first positive EBITDA quarter of
For more information about the conference or to schedule a one-on-one meeting with Bacterin management, contact your Lazard Capital Markets representative.
About Lazard Capital Markets
Lazard Capital Markets LLC provides corporate finance advisory services. It offers mergers and acquisitions, restructuring, and capital raising advisory services. The firm provides equity and fixed income sales and trading services. Additionally, it offers corporate underwriting services. The company was founded in 2005 and is based in
New York, New York
. For more information, please visit
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.